secwatch.observer — SEC 8-K summary
======================================

Issuer:     DELCATH SYSTEMS, INC. (DCTH)
CIK:        0000872912
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001193125-24-286248
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Delcath Systems receives $16.3M from Series E and E1 warrant exercises
----------------------------------------------------------------------

- 1,746,424 warrants exercised; 1,045,157 shares of common stock and 603,954 pre-funded warrants issued.
- Gross proceeds of approximately $16.3 million; ~6.6% of exercises were cashless.
- Warrants had $10.00 exercise price, issued in July/August 2019, expired Dec 24, 2024.
- CEO states cash position strong to fund HEPZATO commercialization and clinical trials.
- Warrant amendments allow pre-funded warrants to avoid exceeding 9.99% beneficial ownership cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872912/000119312524286248/0001193125-24-286248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872912/000119312524286248/d924758d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-286248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer